Erratum to "Development and validation of a clinical radiomics nomogram to predict secondary loss of response to infliximab in Crohn's disease patients" [Heliyon 9(4) (April 2023) e14594]

Heliyon. 2023 May 25;9(6):e16573. doi: 10.1016/j.heliyon.2023.e16573. eCollection 2023 Jun.

Authors

Chao Zhu¹, Xingwei Wang¹, Shihui Wang², Jing Hu³, Yankun Gao¹, Cuiping Li¹, Jianying Li⁴, Xingwang Wu¹

Affiliations

¹ Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
² Department of Radiology, The First Affiliated Hospital of Wannan Medical College, Wuhu, 241001, China.
³ Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
⁴ CT Research Center, GE Healthcare China, Shanghai, 210000, China.

Abstract

[This corrects the article DOI: 10.1016/j.heliyon.2023.e14594.].

© 2023 Published by Elsevier Ltd.

Publication types

Published Erratum